Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,649 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The cell division cycle and the pathophysiology of Alzheimer's disease.
Nagy Z, Esiri MM, Smith AD. Nagy Z, et al. Among authors: smith ad. Neuroscience. 1998 Dec;87(4):731-9. doi: 10.1016/s0306-4522(98)00293-0. Neuroscience. 1998. PMID: 9759963 Review.
Deafferentation of the hippocampus results in the induction of AT8 positive 'granules' in the rat.
Mudher AK, Yee B, Smith AD, Perry VH. Mudher AK, et al. Among authors: smith ad. Neurosci Lett. 2001 Mar 23;301(1):5-8. doi: 10.1016/s0304-3940(01)01593-2. Neurosci Lett. 2001. PMID: 11239703
Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups.
Lehmann DJ, Williams J, McBroom J, Smith AD. Lehmann DJ, et al. Among authors: smith ad. Neuroscience. 2001;108(4):541-54. doi: 10.1016/s0306-4522(01)00464-x. Neuroscience. 2001. PMID: 11738493
Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD. Lanzrein AS, et al. Among authors: smith ad. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):215-27. doi: 10.1097/00002093-199809000-00016. Alzheimer Dis Assoc Disord. 1998. PMID: 9772027
The levels of IL-1beta and IL-6 in the various brain regions were not significantly different in the AD and the non-AD group. ...Low levels of TNF-alpha in the brain areas that showed neuropathology in AD may indicate a dysregulation of the inflammatory proce …
The levels of IL-1beta and IL-6 in the various brain regions were not significantly different in the AD and the non-AD group. …
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
Combrinck M, Williams J, De Berardinis MA, Warden D, Puopolo M, Smith AD, Minghetti L. Combrinck M, et al. Among authors: smith ad. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):85-8. doi: 10.1136/jnnp.2005.063131. Epub 2005 Jun 8. J Neurol Neurosurg Psychiatry. 2006. PMID: 15944180 Free PMC article.
Low free testosterone is an independent risk factor for Alzheimer's disease.
Hogervorst E, Bandelow S, Combrinck M, Smith AD. Hogervorst E, et al. Among authors: smith ad. Exp Gerontol. 2004 Nov-Dec;39(11-12):1633-9. doi: 10.1016/j.exger.2004.06.019. Exp Gerontol. 2004. PMID: 15582279
Elderly AD cases had raised levels of gonadotropins. This response may be an attempt to normalize low free testosterone levels. ...Lowering SHBG and/or screening for subclinical thyroid disease may prevent cognitive decline and/or wasting in men at risk for AD....
Elderly AD cases had raised levels of gonadotropins. This response may be an attempt to normalize low free testosterone levels. ...Lo …
The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach.
Hogervorst E, Bandelow S, Combrinck M, Irani SR, Smith AD. Hogervorst E, et al. Among authors: smith ad. Dement Geriatr Cogn Disord. 2003;16(3):170-80. doi: 10.1159/000071006. Dement Geriatr Cogn Disord. 2003. PMID: 12826744
Cases who had been diagnosed as NINCDS/ADRDA 'probable AD' in life were usually confirmed at autopsy, but half of the NINCDS/ADRDA 'negative' cases were not (low specificity). ...The DSM-IV criteria had good validity for AD when compared with post-mortem confirmatio …
Cases who had been diagnosed as NINCDS/ADRDA 'probable AD' in life were usually confirmed at autopsy, but half of the NINCDS/ADRDA 'n …
Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men.
Lehmann DJ, Butler HT, Warden DR, Combrinck M, King E, Nicoll JA, Budge MM, de Jager CA, Hogervorst E, Esiri MM, Ragoussis J, Smith AD. Lehmann DJ, et al. Among authors: smith ad. Neurosci Lett. 2003 Apr 10;340(2):87-90. doi: 10.1016/s0304-3940(03)00069-7. Neurosci Lett. 2003. PMID: 12668243
We found that short alleles (AD (adjusted odds ratio = 2.5, 95% confidence intervals: 1.2-5.0) in men, but not in women. This association appeared stronger in early-onset AD (<65 years). We conclude that this AR polym …
We found that short alleles (AD (adjusted odds ratio = 2.5, 95% confidence intervals: 1 …
Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.
Hogervorst E, Lehmann DJ, Warden DR, McBroom J, Smith AD. Hogervorst E, et al. Among authors: smith ad. Int J Geriatr Psychiatry. 2002 Oct;17(10):938-40. doi: 10.1002/gps.714. Int J Geriatr Psychiatry. 2002. PMID: 12325053
OBJECTIVES: To assess the association between testosterone levels and APOEepsilon4 in cases with AD and controls. METHOD: We included 61 men with definite or probable Alzheimer's disease (AD) and 55 elderly male controls from the Oxford Project to Investigate Memory …
OBJECTIVES: To assess the association between testosterone levels and APOEepsilon4 in cases with AD and controls. METHOD: We included …
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
Bradley KM, O'Sullivan VT, Soper ND, Nagy Z, King EM, Smith AD, Shepstone BJ. Bradley KM, et al. Among authors: smith ad. Brain. 2002 Aug;125(Pt 8):1772-81. doi: 10.1093/brain/awf185. Brain. 2002. PMID: 12135968
1,649 results
Jump to page
Feedback